WAYS OF PREVENTION AND PHARMACOTHERAPY OF LIVER ECHINOCOCCOSIS

Abstract

The results of treatment with albendazole in 15 patients and prevention in 124 patients with liver echinococcosis were analyzed. With the isolated use of albendazole for therapeutic purposes, 11 (73.3%) patients received positive results. It was established that from the moment of introduction of chemotherapy into the complex of postoperative rehabilitation the frequency of relapses decreased from 8.6 to 0.5%. The incidence of local recurrence of liver echinococcosis was 26.6%. The significant frequency of recurrences of echinococcosis in segments remote from the primary focus (43.4%) and even the defeat of another liver fraction (20%) casts doubts on the role of the fibrous capsule of the primary cyst as the main disease relapse factor